Impact of Blood Pressure Control on Thromboembolism and Major Hemorrhage in Patients With Nonvalvular Atrial Fibrillation: A Subanalysis of the J‐RHYTHM RegistryEitaro Kodani, Hiroyasu Sukekawa, Hirotsugu Atarashi et al.|Journal of the American Heart Association|2016Cited by 61
The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillationHiroaki Shimokawa, Hiroshi Inoue, Nobuyoshi Sugishita et al.|International Journal of Cardiology|2018Cited by 48
Clinical risk factors of stroke and major bleeding in patients with non-valvular atrial fibrillation under rivaroxaban: the EXPAND Study sub-analysisIchiro Sakuma, Hiroaki Shimokawa, Shinichiro Uchiyama et al.|Heart and Vessels|2019Cited by 24
Impact of Blood Pressure Visit‐to‐Visit Variability on Adverse Events in Patients With Nonvalvular Atrial Fibrillation: Subanalysis of the J‐RHYTHM RegistryEitaro Kodani, Tomonori Watanabe, Hiroshi Inoue et al.|Journal of the American Heart Association|2020Cited by 16
Ischemic stroke, hemorrhage, and mortality in patients with non-valvular atrial fibrillation and renal dysfunction treated with rivaroxaban: sub-analysis of the EXPAND studyHirotsugu Atarashi, Hiroaki Shimokawa, Shinichiro Uchiyama et al.|Heart and Vessels|2021Cited by 15